PATENT CLAIM ANALYSIS

Application Number: 16305021
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "108000"]

Abstract:
The present invention is in the field of a use of a bisphophosphonate acid, specifically a salt thereof, or analogue thereof, or combinations thereof, in a medicament for naturally occurring diseases/disorders in a mammal, the mammal being selected from the orders of Perissodactyla, such as the family of Equidae (horses), (Cet) Artiodactyla, such as the family of Bovidae (cattle), and Carnivora, such as the families of Canidae (e.g. dogs) and Felidae (e.g. cats).

Claim (Index 10):
A medicament compound comprising a salt of a nitrogen containing bisphosphonic acid (bisphosphonate) according to  FIG. 1 a wherein R1 is independently selected from H and OH, wherein R2 is independently selected from branched, unbranched, aromatic, non-aromatic cyclic, carbon comprising moieties having 1-12 carbon atoms and at least one of a primary amine, secondary amine, tertiary amine, or heterocycle comprising nitrogen, an analogue of said bisphosphonate, and combinations thereof, for treating a naturally occurring disease/disorder in a mammal, comprising only the bisphosphonate or analogue thereof as active compound, wherein the disease/disorder is one or more of degenerative arthritis, degenerative joint disease, osteoarthrosis, arthritis, and Osteoarthritis, the mammal being selected from the orders of Perissodactyla, (Cet) Artiodactyla, and Carnivora, wherein the medicament is a physiological liquid comprising a dosage of 0.01-1 mg/kg bisphosphonate, wherein the medicament is for application once per 1-12 months, and wherein the medicament is for sub-cutaneous or intravenous or intraperiotenal provision.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.92
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10470924', '12191264', '11911679', '11867919', '14175254']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6875704834442545
- 35 USC 102 Novelty (BERT): 0.4991331758942294
- Combined Prediction Score: 0.6687267526892521
- Mean Citation Score: 177.00638400000005
- Max Citation Score: 189.10039
- Similarity Product: 125.05560520786942

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test